Esperas Pharma, Inc. Announces Investment From Tvm Life Science Innovation I And The Fonds De Solidarité Ftq
Round Type
Venture
MontrealBiotechnologyHealth CareMedicalDescription
Esperas Pharma, Inc. (“Esperas”), a company based in Montréal, Québec, today announced a follow-on investment by TVM Capital Life Science (“TVM”) through its fund TVM Life Science Innovation I SCSp and the Fonds de solidarité FTQ (the “Fonds”). Esperas is developing the first oral Check 1 inhibitor, ESP-001 (formerly LY2880070), a compound originally discovered through a research and development program at Eli Lilly and Company, with the potential to treat certain types of cancers including high-grade serous ovarian cancer (“HGSOC”).
Quick answer
Esperas Pharma raised an undisclosed amount in a funding round, dated February 21, 2023. Esperas Pharma is based in Montreal, Quebec, Canada.
- How much did Esperas Pharma raise?
- Esperas Pharma raised an undisclosed amount in a funding round on February 21, 2023.
- What does Esperas Pharma do?
- Esperas Pharma, Inc. is a special purpose company created to develop one compound to proof-of-concept.
- Where is Esperas Pharma based and how big is it?
- Esperas Pharma is based in Montreal, Quebec, Canada.
Source: Fundz verified event record.
Who else raised in Medical and Biotechnology around the same time
Companies in the same sectors as Esperas Pharma that raised within 45 days of this round, from Fundz verified event records.
- OXOS Medical raised $23M (Series A) on April 5, 2023.
- ClinOne, Inc. raised $11M on April 3, 2023.
- INTRINSIC THERAPEUTICS raised $5.9M on March 29, 2023.
- Kayentis raised $5.4M (Funding Round) on March 28, 2023.
- Streamex Corp. raised $1.5M (Seed) on March 24, 2023.
- Greenbrook TMS raised $8.3M (Debt Financing) on March 24, 2023.
Who to call at Esperas Pharma, and when
A new round usually means Esperas Pharma is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Esperas Pharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Esperas Pharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Esperas Pharma. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Esperas Pharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Esperas Pharma raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.